BioMarin Pharmaceutical | BMRN - Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 295.81M 118M 2026-09
Amgen USD 2.08B 570M 2026-03
Bayer EUR 321M 2.67B 2026-06
Biogen USD 647.3M 269.6M 2026-06
BioMarin Pharmaceutical USD 61.38M 79.82M 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
Incyte USD 751.51M 407.91M 2026-06
Insmed USD -97.65M 86.28M 2026-09
Ionis Pharmaceuticals USD -114M 21M 2026-06
Moderna USD -1.33B 535M 2026-03
Neurocrine Biosciences USD 162.2M 84.6M 2026-06
PTC Therapeutics USD -41.09M 138.63M 2026-09
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR 837M 1.17B 2026-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Ultragenyx Pharmaceutical USD -91M 93M 2026-06
United Therapeutics USD 372.7M 54.4M 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06